Ian A. Critchley

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection

G. Ralph Corey, Mark H. Wilcox, George H. Talbot et al. · Clinical Infectious Diseases · 2010 · 236 citations

Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000

Clyde Thornsberry, Daniel F. Sahm, Laurie J. Kelly et al. · Clinical Infectious Diseases · 2002 · 222 citations · Full text

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Thomas M. File, Donald E. Low, Paul B. Eckburg et al. · Journal of Antimicrobial Chemotherapy · 2011 · 196 citations · Full text

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia

Thomas M. File, Donald E. Low, Paul B. Eckburg et al. · Clinical Infectious Diseases · 2010 · 185 citations · Full text

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Donald E. Low, Thomas M. File, Paul B. Eckburg et al. · Journal of Antimicrobial Chemotherapy · 2011 · 185 citations